PAM
VNRX icon

Panagora Asset Management’s VolitionRx Ltd VNRX Stock Holding History

Panagora Asset Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-588
Closed -$38K – 2949
2020
Q3 		$38K Hold
588
– – ﹤0.01% 2082
2020
Q2 		$46K Buy
+588
New +$42.5K ﹤0.01% 2001

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Panagora Asset Management's VNRX Position: Q4 2020 in Review

Panagora Asset Management sold out of VolitionRx Ltd (VNRX) in Q4 2020, closing a stake of 588 shares — an estimated $38K sold.

Panagora Asset Management first reported a position in VNRX in Q2 2020 and held it in 2 quarters. The position peaked at $46K in Q2 2020. 45 funds tracked by Wall St. Rank hold VNRX as of Q4 2020.

  • Panagora Asset Management reported no remaining VolitionRx Ltd position as of Q4 2020 after selling out during the quarter.
  • Panagora Asset Management sold 588 VolitionRx Ltd shares in Q4 2020, an estimated $38K.
  • Panagora Asset Management first reported a position in VolitionRx Ltd in Q2 2020 and held it in 2 quarters.
  • Panagora Asset Management's VolitionRx Ltd position peaked at $46K in Q2 2020.
  • 45 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.